Coleen Glessner
Förmögenhet: 2 M $ per 2026-05-31
Förmögenhet: 2 M $ per 2026-05-31
Coleen Glessner is currently Executive VP-Quality, Ethics & Compliance at Emergent BioSolutions, Inc. since 2020.
Formerly, Ms. Glessner was Chief Quality Officer & Senior Vice President at Alexion Pharmaceuticals, Inc. from 2017 to 2021 and also served as VP, Head-R&D Quality at Alexion Pharmaceuticals,.
Inc. Education includes an undergraduate degree from the University of Pittsburgh and an MBA from the Massachusetts Institute of Technology.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-08 | 202 201 ( 0,39 % ) | 2 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Compliance Officer | 2020-03-01 |
| Företag | Position | Slut |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Företagsledare/Principal | 2021-08-01 |
| ALEXION PHARMACEUTICALS, INC. | Företagsledare/Principal | 2021-08-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
University of Pittsburgh
University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Emergent BioSolutions, Inc.
Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån